The effects of melatonin in the treatment of delirium-a double blind, randomized, placebo-controlled trial.
- Conditions
- delirium, medically-ill, elderly patients.delier, interne-aandoeningen, oudere patienten.
- Registration Number
- NL-OMON21861
- Lead Sponsor
- Academic Medical CenterAmsterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. Age 65 years or older;
2. Acute hospital admission at medical ward;
Exclusion Criteria
1. Patients on medication that can’t speak or understand Dutch;
2. Patients diagnosed with delirium who have received anti-psychotics longer than 24 hours;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method